Newron FDA Clinical Hold Continues: Evenamide Safety Flag
FDA keeps its hold on Newron US schizophrenia trial, citing a possible cardiac safety signal for evenamide. What is known and what comes next.
FDA keeps its hold on Newron US schizophrenia trial, citing a possible cardiac safety signal for evenamide. What is known and what comes next.